STEMETIL prochlorperazine mesilate 12.5 mg/mL Injection ampoule (export)

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

prochlorperazine mesilate, Quantity: 12.5 mg/mL

Disponible depuis:

Sanofi-Aventis Australia Pty Ltd

DCI (Dénomination commune internationale):

prochlorperazine mesilate

forme pharmaceutique:

Injection

Composition:

Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride

Mode d'administration:

Intramuscular

Unités en paquet:

10 x 1 mL

Type d'ordonnance:

(S1) This Schedule is intentionally blank

indications thérapeutiques:

STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

Descriptif du produit:

Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2007-07-16